Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre

por Wang, Huafeng, Wang, Ming, Wei, Juying, Wang, Lei, Mao, Liping, Jin, Jie
Publicado 2017

A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3

por Wei, Juying, Pan, Youlu, Shen, Zheyuan, Shen, Liteng, Xu, Lei, Yu, Wenjuan, Huang, Wenhai
Publicado 2023

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies

por Zhang, Piaopiao, Wang, Jie, Hu, Hangbin, Zhang, Sheng, Wei, Juying, Yang, Qing, Qu, Tingting
Publicado 2020

Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy

por Yang, Chunmei, Lei, Wen, Xie, Hongqiong, Wu, Gongqiang, Wei, Juying, Liang, Aibin, Qian, Wenbin
Publicado 2020

The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses

por You, Liangshun, Mao, Liping, Wei, Juying, Jin, Shenhe, Yang, Chunmei, Liu, Hui, Zhu, Li, Qian, Wenbin
Publicado 2017

Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL

por Liu, Hui, Yang, Chunmei, Zhao, Xiaoyan, Le, Jing, Wu, Gongqiang, Wei, Juying, Liang, Yun, Qian, Wenbin
Publicado 2020

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

por Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
Publicado 2021

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

por Hu, Chao, Yu, Mengxia, Ren, Yanling, Li, Kongfei, Maggio, Dominic M., Mei, Chen, Ye, Li, Wei, Juying, Jin, Jie, Zhuang, Zhengping, Tong, Hongyan
Publicado 2017

Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

por Hu, Chao, Yu, Mengxia, Ren, Yanling, Li, Kongfei, Maggio, Dominic M., Mei, Chen, Ye, Li, Wei, Juying, Jin, Jie, Zhuang, Zhengping, Tong, Hongyan
Publicado 2017

Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center

por Zhu, Yanan, Zhang, Xiang, Wei, Juying, Yang, Chunmei, Tong, Hongyan, Mai, Wenyuan, Yang, Min, Qian, Jiejing, Mao, Liping, Meng, Haitao, Jin, Jie, Yu, Wenjuan
Publicado 2022

Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML

por Ling, Qing, Zhou, Yutong, Qian, Yu, Qian, Jiejing, Zhang, Yi, Wang, Jinghan, Zhu, Yanan, Zhou, Yile, Wei, Juying, Yang, Chunmei, Sun, Jie, Yu, Wenjuan, Jin, Jie, Zhang, Xiang
Publicado 2023

Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients

por Xu, Yi, Shen, Huafei, Shi, Yuanfei, Zhao, Yanchun, Zhen, Xiaolong, Sun, Jianai, Li, Xueying, Zhou, De, Yang, Chunmei, Wang, Jinhan, Huang, Xianbo, Wei, Juying, Huang, Jian, Meng, Haitao, Yu, Wenjuan, Tong, Hongyan, Jin, Jie, Xie, Wanzhuo
Publicado 2023

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

por Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
Publicado 2017

Outcomes in refractory diffuse large B‐cell lymphoma: results from a multicenter real‐world study in China

por Wang, Shuo, Wang, Li, Hu, Jianda, Qian, Wenbin, Zhang, Xi, Hu, Yu, Zhu, Qi, Chen, Bobin, Wu, Depei, Chang, Chung‐Chou H., Xu, Pengpeng, Zheng, Xiaoyun, Wei, Juying, Liu, Yao, Cui, Guohui, Tang, Yong, Ma, Yan, Huang, Haiwen, Yi, Hongmei, Zhao, Weili
Publicado 2021

The clinical impact of IKZF1 mutation in acute myeloid leukemia

por Zhang, Xiang, Huang, Aijie, Liu, Lixia, Qin, Jiayue, Wang, Chengcheng, Yang, Min, Lou, Yinjun, Wang, Lei, Ni, Xiong, Hu, Xiaoxia, Tang, Gusheng, Zhang, Mengmeng, Cao, Shanbo, Mao, Liping, Qian, Jiejin, Xu, Weilai, Wei, Juying, Xu, Gaixiang, Meng, Haitao, Mai, Wenyuan, Yang, Chunmei, Zhu, Honghu, Tong, Hongyan, Yang, Jianmin, Yu, Wenjuan, Wang, Jianmin, Jin, Jie
Publicado 2023

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study

por Qian, Jie‐Jing, Hu, Xiaoxia, Wang, Ying, Zhang, Yi, Du, Juan, Yang, Min, Tong, Hongyan, Qian, Wen‐Bin, Wei, Juying, Yu, Wenjun, Lou, Yin‐Jun, Mao, Liping, Tao Meng, Hai, You, Liang‐Shun, Wang, Libing, Li, Xia, Huang, Xin, Cao, Li‐Hong, Zhao, Jian‐Zhi, Yan Yan, Xiao, Chen, Yu‐Bao, Chen, Yu, Zhang, Su‐Jiang, Jin, Jie, Hu, Jiong, Zhu, Hong‐Hu
Publicado 2020

Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study

por Zhong, Huijuan, Cheng, Shu, Zhang, Xi, Xu, Bing, Chen, Jiayi, Jiang, Xufeng, Xiong, Jie, Hu, Yu, Cui, Guohui, Wei, Juying, Qian, Wenbin, Huang, Xiaobing, Hou, Ming, Yan, Feng, Wang, Xin, Song, Yongping, Hu, Jianda, Liu, Yuanhua, Ma, Xuejun, Li, Fei, Wu, Chongyang, Chen, Junmin, Yu, Li, Bai, Ou, Xu, Jingyan, Zhu, Zunmin, Liu, Li, Zhou, Xin, Huang, Li, Tong, Yin, Niu, Ting, Wu, Depei, Zhang, Hao, Wang, Chaofu, Ouyang, Binshen, Yi, Hongmei, Song, Qi, Cai, Gang, Li, Biao, Liu, Jia, Li, Zhifeng, Xiao, Rong, Wang, Luqun, Jiang, Yujie, Liu, Yanyan, Zheng, Xiaoyun, Xu, Pengpeng, Huang, Hengye, Wang, Li, Chen, Saijuan, Zhao, Weili
Publicado 2023